Etoscrib Sp Tablet Etoricoxib IP 60 mg Serratiopeptidase IP 10 mg Tablet – Manufacturer, Supplier & PCD Franchise



Etoscrib Sp Tablet Etoricoxib IP 60 mg Serratiopeptidase IP 10 mg Tablet — available for PCD franchise from Trumac Healthcare

Etoscrib Sp Tablet Etoricoxib IP 60 mg Serratiopeptidase IP 10 mg Tablet

Etoscrib Sp Tablet Etoricoxib IP 60 mg Serratiopeptidase IP 10 mg — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing

Composition: Etoscrib Sp Tablet Etoricoxib IP 60 mg Serratiopeptidase IP 10 mg
Form: Tablet
Class: selective COX-2 inhibitor + proteolytic enzyme
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ Available Now

Pricing, brochure & monopoly territory within 24 hrs.

Etoscrib Sp Tablet Etoricoxib IP 60 mg Serratiopeptidase IP 10 mg Tablet is available from Trumac Healthcare, a PCD pharma franchise company and supplier in India whose products are made at WHO-GMP certified partner units. This tablet formulation is offered on monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing basis across all Indian states.

Therapeutic Indications
  • The combination is used as the prescribing doctor decides; what each ingredient is used for:
  • Etoricoxib (selective COX-2 inhibitor): Osteoarthritis and rheumatoid arthritis; Ankylosing spondylitis
  • Serratiopeptidase (Serrapeptase) (proteolytic enzyme): Swelling and inflammation after surgery or injury; Adjunct in inflammatory conditions such as sinusitis and after dental procedures
Mechanism of Action

Etoricoxib: Etoricoxib selectively inhibits cyclo-oxygenase-2, reducing prostaglandins that mediate pain and inflammation while largely sparing COX-1, which helps protect the stomach lining.

Serratiopeptidase (Serrapeptase): Serratiopeptidase is a proteolytic enzyme originally obtained from Serratia bacteria. It is thought to break down inflammatory proteins and fibrin, helping to thin secretions and reduce swelling at the site of inflammation.

Dosage & Administration
  • Dosage of Etoscrib Sp Tablet Etoricoxib IP 60 mg Serratiopeptidase IP 10 mg Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
  • Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
  • Do not exceed the prescribed dose, and complete the full course as advised.
  • Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
  • To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
  • Oedema and fluid retention
  • Raised blood pressure
  • Dyspepsia and abdominal pain
  • Nausea, stomach upset and loss of appetite
  • Diarrhoea
  • Skin rash or allergic reactions
  • Report any unexpected symptom to the prescribing doctor
Contraindications & Precautions
  • Known hypersensitivity to any ingredient of the formulation
  • Uncontrolled hypertension
  • Ischaemic heart disease, stroke or heart failure
  • Bleeding disorders or use with anticoagulants or antiplatelets
  • Before planned surgery
Storage

Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.

From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the general range products product list (PDF). See our full PCD franchise tablets range. Comparing companies? See the general range PCD companies compared. No franchise fee; minimum first order ₹25,000 – cost and documents.


For chemists, distributors and doctors: need Etoscrib Sp Tablet Etoricoxib IP 60 mg Serratiopeptidase IP 10 mg Tablet for a PCD franchise or wholesale? Trumac Healthcare checks availability with its WHO-GMP certified partner units and quotes on enquiry – no franchise fee; first order from ₹25,000.

WhatsApp your requirement

See the full pain relief & muscle relaxant range – manufacturer, supplier and PCD franchise: aceclofenac, diclofenac, etoricoxib, lornoxicam, paracetamol, serratiopeptidase, thiocolchicoside and tizanidine.

PCD Pharma Franchise & Third Party Manufacturing — Etoscrib Tablet

  • ✓ Made at WHO-GMP certified partner units — every batch QC released
  • ✓ Monopoly PCD franchise rights at district or state level
  • ✓ Third party / contract manufacturing under your own brand
  • ✓ Wholesale and distributor supply against drug licence + GST
  • ✓ Attractive net rates with healthy PTR / PTS margins
  • ✓ Dispatch within 48 hours of payment realisation

Composition: Etoscrib Sp Tablet Etoricoxib IP 60 mg Serratiopeptidase IP 10 mg. Trumac Healthcare supplies this prescription pharmaceutical formulation with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.

PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Etoscrib Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.

Frequently Asked Questions

Who manufactures Etoscrib Tablet in India?

Trumac Healthcare is a supplier of Etoscrib Tablet in India; products are made at WHO-GMP certified partner units. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.

Is Etoscrib Tablet available for PCD pharma franchise on monopoly basis?

Yes. Etoscrib Sp Tablet Etoricoxib IP 60 mg Serratiopeptidase IP 10 mg Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.

Do you offer Etoscrib for third party or contract manufacturing?

Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Etoscrib Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.

Can Etoscrib Tablet be supplied on wholesale or distributor basis?

Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.

What is the therapeutic class of Etoscrib?

Etoscrib combines Etoricoxib (selective COX-2 inhibitor) and Serratiopeptidase (Serrapeptase) (proteolytic enzyme).

What documentation is provided with each supply?

Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.

How quickly can an order be dispatched?

Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.

Is a prescription required for Etoscrib Tablet?

Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.

Ready to start your PCD franchise for Etoscrib Sp Tablet Etoricoxib IP 60 mg Serratiopeptidase IP 10 mg Tablet?

Get Pricing & Franchise Terms →